Members

Covestro is a world-leading supplier of high-tech polymer materials: innovative, sustainable, and diverse.

We are serving key industries (such as automotive, construction, and electro/electronics) around the globe with technologically leading processes. Our products and application solutions are used in many areas of modern life.

In line with our vision “To make the world a brighter place,” we work on solutions to the challenges of our time. Alternative raw materials (such as biomass) and alternative production concepts (e.g. via biotechnology) are the basis for various new innovation-driven products and production processes.

With approximately 16,770 employees Covestro posted sales of 14.6 billion euros in 2018. It has some 30 major production sites worldwide that operate in a safe, efficient and ecofriendly way. The product range includes the high-performance polymer polycarbonate and precursors for polyurethanes that are used to produce foam.

Evonik stands for appealing businesses and innovative strength. Around 80 percent of our sales come from market-leading positions. We work in a results-focused corporate culture that is geared to profitable growth and increasing the value of the company. Our strengths include the balanced spectrum of our business activities, endmarkets, and regions as well as close collaboration with our customers. More than 36,000 employees are bound by a claim: No product is so perfect that it couldn’t be made better.

Henkel operates globally with a well-balanced and diversified portfolio. The company holds leading positions with its three business units - Laundry & Home Care, Beauty Care and Adhesives - in both industrial and consumer businesses thanks to strong brands, innovations and technologies. Founded in 1876, Henkel looks back on more than 140 years of success. Henkel’s preferred shares are listed in the German stock index DAX. The DAX-30 company has its headquarters in Düsseldorf, Germany.

Henkel employs more than 50,000 people worldwide, over 80 percent of whom work outside of Germany. As a recognized leader in sustainability, Henkel holds top positions in many international ratings and rankings. In the fiscal year 2016, the company reported sales of approx. 18.7 billion euros and an operating profit of around 3.2 billion euros (adjusted for one-time gains/charges and restructuring charges).

LANXESS – at the heart of the chemical industry LANXESS is a leading specialty chemicals company with sales of EUR 7.2 billion in 2018. The company currently has about 15,400 employees in 33 countries and is represented at 60 production sites worldwide. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives, specialty chemicals and plastics. LANXESS is listed in the leading sustainability indices Dow Jones Sustainability Index (DJSI World and Europe) and FTSE4Good.

Aachen Proteineers is a biotechnology incubator under development with close ties to the RWTH Aachen (Prof. Schwaneberg) and the University of Bonn (Prof. Bröring). Currently, we are focusing on a platform technology that enables us to bind various biomolecules to a wide range of surfaces using special peptides. This technology intensifies processes, cuts cost, and achieves very high coating densities in water at room temperature. We tailor these peptides regarding application conditions, surface specificity, and binding strength through protein engineering strategies, such as directed evolution. We are currently evaluating products for research, diagnostics and process technology markets, and are open to discussing new applications and to exploring them in partnerships.

aquila biolabs is a German biotechnology start-up company focusing on the development of innovative laboratory devices for the control and analysis of bioprocesses in bioreactors and incubation shakers. The founding idea was a product for hassle-free biomass sensing, the Cell Growth Quantifier (CGQ). The CGQ is a sensor-based technology that offers highly parallelized, non-invasive online monitoring of biomass in shake flasks and bioreactors The second product line, the Liquid Injection System (LIS), allows for automated feeding of liquids in shake flasks. This automated miniature pump is the first commercially available technology of its kind and can be used for a broad range of applications. aquila biolabs was founded in 2014 and was ranked among the TOP 10 start-ups in Germany in 2015.

Autodisplay brings proteins and peptides to the surface of gram negative bacteria. The transport of molecules to the bacterial surface avoids protein expression issues such as inclusion bodies and incorrect folding. With our proprietary cell surface display technology, we create custom-tailored solutions for our clients. Services include:

1. High-throughput screening of binding interactions and enhanced enzyme activity via FACS.

2. Development of whole cell biocatalysts that combine the benefits of soluble enzymes and classic whole cell biocatalysts - no limitations regarding permeability of substrate or product, yet easy recovery of the biocatalyst for re-use.

3. Functionalisation of solid surfaces with the highest levels of control regarding target molecule orientation. Autodisplay helps prevent the activity loss by-effect which occurs during immobilisation.

Axxence Aromatic was founded in 1986 and is a privately held company with head office in Emmerich, Germany. Over the years our focus has been entire dedication to be one of the most reliable and innovative sources within our prime field of expertise: NATURAL AROMA INGREDIENTS for the flavour & fragrance industry worldwide. By strategic investments in R&D of both novel natural ingredients and new manufacturing processes, we constantly strive to expand the use of our products in existing and new applications as well as markets. Axxence has around 100 employees. Sales offices and warehousing are present in Germany, France, USA and Japan. Manufacturing and R&D facilities are located in the Slovak Republic.

b.fab is specialized in the efficient conversion of CO2 and hydrogen (H2) from renewable energy into biotechnological value chains. CO2 and water are abundantly available and therefore it is our starting point to build a sustainable bioeconomy. We use formate as our central mediator to bind and store CO2 and H2 (made from water) in liquid form. Our bioprocesses start with the feedstock formate and we use Synthetic Biology to design specific pathways and to convert formate into value-added chemicals. Our platform is build on anaerobic and aerobic microbial production hosts to provide flexibility in the process design and adaptation to specific product requirements. b.fab offers strains, bioprocesses and technology licences.

Bio Base Europe Pilot Plant is an open innovation pilot and demonstration facility for process development, scale-up and custom manufacturing of biobased products and processes from lab to multi ton scale. A wide and flexible spectrum of modular unit operations combined with a team of highly trained and experienced engineers, process operators and technicians facilitates the translation of biobased laboratory processes into viable industrial processes.

Bio Base Europe Pilot Plant has successfully performed 200 projects for more than 100 companies and has been involved in over 30 public projects. It currently coordinates SmartPilots (Improve policies in support of shared pilot facilities and their users) and BioBase4SME (Bio-innovation support for entrepreneurs throughout North-West Europe).

BIOMILLENIA, a France-based privately held company, is a leading technology solution provider for the development of novel green chemistry products. BIOMILLENIA’s disruptive BIOMILLENIA DIMENSION 300X platform, based on licensed technology that was developed by Harvard University, the BROAD Institute and ESPCI Paris, uniquely combines advanced genomics and bioinformatics technologies with microfluidics-based ultrahigh-throughput screening. This unique technology platform delivers novel microbes, production strains and enzymes for manufacture of chemicals and natural products at throughputs and speeds several orders of magnitudes higher than with traditional methods. BIOMILLENIA “Unlocks Nature’s Potential” for cost-competitive and sustainably manufactured novel biology-based products for a better life.

The Bioprocess Pilot Facility B.V. is a unique open access facility, situated at the Biotech Campus Delft, the Netherlands. Companies and knowledge institutions can upscale new sustainable production processes by converting bio-based residues into useful chemicals or fuels and production processes for Food and Pharma.
The facility has been specifically designed to enable the transition from laboratory to industrial scale.

We have 4 different pilot plants which can interact:
· Pretreatment of biomass on benchscale and pilot scale.
· Fermentation from 10 l up to 4m3. (ATEX, GMO)
· Downstream processing, chemical processing (ATEX)
· Food grade pilot plant.

The upscaling of the lab process can be proven on pilot scale with a good prediction of the process on commercial scale.

biotechrabbit GmbH was founded in 2011 in Henningsdorf; already 4 years later in 2015 a second research and production site was opened in Berlin/Adlershof. Biotechrabbit is a team of top class scientists, experienced managers and business developers who are determined to offer highest quality products and services for diagnostic companies and life science research. We value the relationships with our partners and customers and are driven to exceed current limitations with flexibility, innovation and highly customized solutions to match specific requirements. Biotechrabbit’s offering includes enzymes for molecular diagnostics, antibody generation and production, high-capacity protein fermentation, lyophilization for diagnostic test kits and pharma, highly parallel, cell-free protein synthesis, mRNA for therapeutics, site-directed amino acid incorporation for labeling or cancer biotherapeutics and a full molecular biology products catalog. Our way of doing business combines the passion and pure curiosity of excellent researchers with the agile spirit of true entrepreneurs.

bitop AG is a biotechnology company focused on products based on extremolytes, a group of natural protective molecules responsible for the stress resistance of extremophilic microorganisms. bitop develops and employs fermentative and biocatalytic bioprocesses for extremolyte production. The company offers innovative medical devices based on the extremolyte Ectoin® in the areas of allergy, dermatology, respiratory diseases and dry epithelia with scientifically confirmed efficacy and tolerability. Furthermore bitop offers extremolyte products like Ectoin®, Glycoin®, and 28Extremoin® as cosmetic active ingredients as well as hydroxyectoin as biostabilizer for diagnostics and life sciences.

BluCon technology platform is a so-called second generation biomass conversion technology. BluCon is a platform for complete, one-step conversion of non-food feedstocks to carbohydrates used in the production of fuels and chemicals. The BluCon platform is based on its patented, proprietary extremophilic anaerobic bacteria and offers significantly improved process economics compared to other second generation conversion processes. BluCon converts various non-food biomass ranging from grasses and straw to agricultural and wood residues and can therefore be applied around the globe.

The b.value AG invests in biotechnology and chemistry startups and focusses on companies and founder teams in Germany, Austria and Switzerland. Investments specifically focusses on health and nutrition, resource efficiency, and digitization. The goal of the b.value AG is to build a long-term portfolio of fast-growing, young biotech companies, whose product or business model include a disruptive innovation, high scalability, or whose founders and managers are expected to succeed through their entrepreneurial skills. The b.value AG acquires majority and minority interests. In almost all cases, it invests in the Seed Stage together with other co-investors (serial entrepreneurs, business angels, venture capital providers), who share our committments through know-how and equity investments.

c-LEcta is a leading industrial biotechnology company, using best-in-class biotechnologies to efficiently provide customized enzymes and microbial strains to industrial applications. Scientific excellence is combined with in-depth commercial and regulatory know-how to bring innovative and competitive bioprocessed products into scale. Besides our in-house project and product pipeline we have a strong focus on strategic cooperation with industrial partners. Moreover, c-LEcta is an established enzyme supplier, manufacturing unique, qualitycontrolled enzyme products on large technical scale.

Concord Blue is a waste management company that transforms nearly any form of local waste into a variety of clean, renewable fuels. Concord Blue has developed a revolutionary closed-loop system that efficiently and cost-effectively produces the highest quality sustainable energy with virtually no pollutants. Unlike other available waste-to-energy processes, Concord Blue’s unique technology benefits the environment, fulfilling all international, EPA and European regulations for renewable energy and air emissions.

Corbion is the global market leader in lactic acid, lactic acid derivatives, and a leading company in emulsifiers, functional enzyme blends, minerals, vitamins and algae ingredients. We develop sustainable ingredient solutions to improve the quality of life for people today and for future generations. For over 100 years, we have been uncompromising in our commitment to safety, quality and performance. Drawing on our deep application and product knowledge, we work side-by-side with customers to make our cutting edge technologies work for them. At Corbion, we live our brand promise "Keep creating", through our science, clear understanding of the markets we serve, and of course through our creative people. Corbion’s strategy and every aspect of our operations are built around advancing sustainability and applying high ethical standards, whether this relates to the management of our global supply chain, responsible procurement of our raw materials, or the safety and wellbeing of our people.

Since 2002 Corvay provides consulting and project management services. We are proud to look at a successful track record, e.g. BioRegioN, Vakzine Projekt Management, Direvo Industrial Biotechnology. Corvay actively supports Sino-German collaboration in biotechnology. Now Corvay has built a specialty chemicals business, marketing and selling specialties from Chinese and Indian suppliers. Long chain aliphatic diacids are sold under the brandname Himount Europe, long chain diols and diamines complete this portfolio, which also covers specialty enzymes and vitamin D. Our success factors: high performance over many years, broad operational expertise in biotechnology, enzymes, vaccines, pharmaceuticals, and internationality, international management experience plus an efficient business network.

DASGIP has been an industry-leading supplier of benchtop bioreactor solutions for the biotech, pharmaceutical and chemical industries as well as academia and research institutions, since 1991. Our Parallel Bioreactor Systems for the cultivation of microbial, plant, animal and human cells utilize industry-standard benchtop glass and single-use bioreactors.

DASGIP's best-in-class configurable control systems and state-of-the-art bioprocess analyzers deliver unparalleled functionality coupled with user-friendly design for optimal bioprocessing. Our proven solutions for interconnectivity to 3rd party bioprocess analyzers, supervisory control systems and DoE tools, combined with our best-in-class control systems, enable migration strategies for optimization of legacy benchtop bioreactor equipment. The outstanding DASGIP bioprocess solutions support QbD-driven process development.

With effect from January 2012 DASGIP is an Eppendorf company. DASGIP is headquartered in Juelich (Germany) and has operations throughout Europe, North America and Asia.

Dutch DNA Biotech (DDNA) started in 2015 as a management buyout from TNO with the mission to contribute to the society by developing sustainable fungi-based production processes for innovative products. DDNA has a mixed business model; in addition to contract research for third parties DDNA develops proprietary technology and IP which is out-licensed. The DDNA team consists of molecular biologists and fermentation experts; of its 19 employees 8 have a PhD. The CSO, Professor Dr. Peter Punt, holds a chair at Leiden University. The company is based at the Science Park of Utrecht University, The Netherlands.

Ecotradex GmbH is focused on facilitating innovations and business development for bio-based, renewable and recyclable materials. This is realized through three fields of activity: offering suitable machine building solutions for mechanical processing of bio-based raw materials, trading in bio-based materials, and innovation consulting in the bio-based field. We offer, for example, packaging materials based on bio-plastics and cellulosic fiber based solutions to replace plastics based on fossil feedstocks.

A company born to bring to the materials industry innovative performing and sustainable products suitable for a variety of applications including CASE, foams, composites, food, cosmetics, pharma. In 2017 , the company started actively with supplying cardanol derived polyols for rigid foams. The first business project in its activity. Since 2017 we have been focusing on the industrial application of such products at the global level, for the large extent. Marginally, since recently the company has been active in implementing the same and new products in CASE applications at industrial scale.

ERBER Enzymes is a spin-off company of EFB, ERBER Future Business GmbH, ERBER Group's in-house incubator. ERBER Enzymes GmbH is headquartered in Dortmund, Germany, and with our focus on microbiological and enzymatic solutions we address selected food and feed markets. According to our customers' needs, we develop suitable specialty enzymes or microbial strains in close cooperation with our sister companies at ERBER Group or in direct cooperation with leading market participants. In line with the core competencies within the group, we focus on food and feed safety; however, we also walk new paths in markets ERBER Group has not yet addressed.

evoxx technologies GmbH, a German Industrial Biotechnology Company, is focusing on the development and production of industrial enzymes and novel carbohydrate ingredients produced by enzymatic bioconversion. With its proprietary enzymes and carbohydrate ingredients, evoxx is active in high growth markets addressing consumer needs in the Global Food Health & Wellness Sector and Consumer Products Markets.

Product development is based on the proprietary technology and patent platform covering the whole value chain from early enzyme and process development to industrial scale production and product deregulation. evoxx industrial partners and customers benefit from the unique metagenomics libraries, the enzyme and carbohydrate development skills and tech-transfer and production capabilities. evoxx is located on the Creative Campus in Monheim am Rhein and on the Biotech Campus Hermannswerder in Potsdam.

The company Heinrich Frings GmbH & Co. KG is a worldwide supplier of machines, equipment and components for process technology in the industry sectors food, biotechnology and chemical industry as well as environmental technology with special focus on fermenters/ bioreactors.

FRINGS not only supplies customized systems for each application, but it also offers assistance and consulting services with its know how and experience concerning process optimization and product development. For downstream processing FRINGS delivers membrane filtration systems (crossflow filtration) for many different industry sectors.

Holiferm develops holistically improved fermentation technology giving massive fermentation and downstream cost reductions for biosurfactant production. Holiferm is a technology development company that holds proprietary technology developed by their founders at The University of Manchester, UK. Their technology uses gravity separation to recover insoluble lipids as they are produced by fermentation and has been demonstrated to pilot scale with sophorolipid biosurfactants, doubling titre and productivity and reducing costs by >50%. Holiferm's technology has been demonstrated to double the state of the art for two of the most economically important KPIs of the sophorolipid production process, reaching titres >800 g/l and productivities >5 g/l/h, leading to large reductions in the cost of production.

INOSIM Consulting GmbH is a German company providing sophisticated technological advice and simulation services for process industries and biotechnology. Our engineering and simulative methods for the design and optimization of biotechnological processes allow setting up the mass and energy balances of a process, applying as little experimental and process data as possible. Thereby, alternative process ideas can be evaluated in both process design and scale-up as well as in the optimization of existing processes and plants. Looking at the complete process and plant with all interdependencies in-between helps to develop resource-saving processes and production plants. Besides the resource efficiency, production costs and capacity can, of course, be included in the rating as well.

The Jäckering group of companies has developed over 100 years (date of foundation 1910) into a small group of various activities:

- wheat starch production (ca. 300.000 tons wheat input per year)

- machinery production (grinders and dryers on the bases of air turbulence mills)

- by-product-recycling in the PVC industry

- logistics and warehousing

Jäckering disposes of a relatively large industrial site in the harbour of Hamm (harbour Hamm is one of the largest canal harbours in Germany), with neighbouring companies in the businesses of vegetable oil production, animal feed compounding as weil as a petrochemical harbour for mineral oil, heating oil, etc„ Jäckering plans to move into biotechnology production of raw materials for the chemical industry on the bases of its by-products, this could be Butandiol, Butanol or Butadien.

Same research is already carried out together with leading university institutes, and a technical application center is under construction.

Marketing and consulting for
• renewable energy,
• lubrication,
• tribology,
• fuel and lubricant market
• Training programs,
• management of demo projects and fleet tests
• B2B Events

The Kuhner Shaker GmbH distributes shaking machines and applications technologies for shaken bioreactor systems. Moreover, we develop and produce innovative products for the substrate release in shaken bioreactors. Our product portfolio covers bench top shakers, feeding and application technologies as well as industrial shaking machines for the production of pharmaceutical agents. Our company is driven by a personal and trustful contact with our customers. Due to long-term experience and expert knowledge we are able to offer optimal and costom-made solutions for our customers. Finally, we actively contribute in research project and represent a partner of the science.

Founded in 2005, LanzaTech has developed a fully integrated gas to liquid technology platform that produces fuels and chemicals from gas resources. The potential feedstock ranges from industrial waste gases (steel mills, refi neries and phosphorous plants) to biomass syngas (MSW, organic industrial waste, and agricultural waste); as well as biogas.

LanzaTech employs a strong technical team based in the USA, China and Europe and has a rapidly growing patent portfolio. With agreements now in place across a variety of sectors internationally, including steel, aviation, refi ning and chemicals, LanzaTech’s technology is being scaled to commercial production.

LXP is a tech company, active in the fi eld of industrial biotechnology. Object of the company is the development, marketing and licensing of technical solutions for the economic and ecological processing of plant residues on the basis of closed carbon and mineral cycles. Our mission is to maximize the ecological and economic effi ciency of biotechnological processes. The core technology is based on a patent protected pre-treatment process called LXProcess. The process provides alternative/2G-carbohydrates/-sugars and is easy to integrate into biotechnological processes. It allows the conversion of virtually all carbohydrates of lignocellulosic non-food materials to chemicals or biofuels. Additionally, sulphur free lignin can be provided.

Mial GmbH is a producer of organic Chlorella at its production facility in Bad Zwischenahn. Using Chlorella and other microalgae as a source for the development and production of new active pharmaceutical ingredients Mial positions itself as a developer of new nutraceutical formulations. Special interest in the development and use of novel carbohydrate mixtures, derived from various microorganisms. The complex mixtures may act as ingridients for nutraceutical, cosmetic and veterinary applications. Additional R&D interest lies in the discovery and manipulation of new pigment production pathways in selected microalgae.

Mitsui & Co. Deutschland GmbH is a subsidiary of Mitsui & Co., Ltd., one of the most diversified and comprehensive trading, investment and service enterprises which covers a wide range of industries: Metals, Machinery & Infrastructure, Chemicals, Nutrition & Agriculture, Energy, Lifestyle, and Innovation & Corporate Development. We currently comprise 136 sites in 66 countries and a network of nearly 500 affiliates, employing more than 42,000 talented people worldwide. In every arena, Mitsui & Co. provides high added value services and solutions that truly reflect our customers’ needs. Our job is to imagine new businesses and bring them to life. Creating new value for this era and innovating for the next.

We favour renewable over finite-supply, but prefer those technologies that require little or no subsidies to thrive, commercially viable concepts will ultimately stand the test of time. We believe the best long-term effects are achieved when each component in biomass is utilised to its full potential.

With respect to wood, this means preferring advanced value chains over simple usages. Our vision calls for a Biofuture that goes beyond traditional solutions. We see danger in over-simplified calls for anything renewable, and prefer an integrated approach to biomass and biotechnology. There are immense opportunities open to those who want to take today’s bioeconomy to the next stage - the Biofuture, but only if innovation and commercial sense advance hand in hand! Our newest tool for driving bio-innovation is the BioFutureFactory(™), of which more on our website.

Nouvellune GmbH is active in the development and sales of special bio-based ingredients and bio-active compounds in Germany, Switzerland and Austria. This includes the development, production and sales of Pro- & Prebiotics (Food & Feed), Extracts, Special Branded Ingredients, APIs, Vitamins & Minerals, but also vegan meat substitutes produced through High Moisture Extrusion through it's brand "Stemmler". In addition, the company is researching in the area of alternative proteins because of it’s passion for sustainability. Last but not least, Nouvellune belongs to a larger conglomerate of companies named Phytonet AG, which is active in the above areas in 8 countries in Middle East & South East Asia, whereas Sourcing, Trading, Regulatory and Local Market Access play an additional role.

Applied research for your needs

As a private and independent institute, nova has over two decades of experience in the bio- and CO2-based economy, conducting research projects and consultancy as well as conference management and dissemination.

nova experts come from a wide range of backgrounds, including material sciences, economics, chemistry, biology, environmental sciences, biotechnology and physics. This gives nova a unique understanding of the bio-based economy, markets and trends and enables it to support your business. nova surrounds, strengthens and completes scientific and engineering work by linking it to feedstock, markets, ecology, economy and policy. nova offers research and consultancy with a focus on bio-based economy in the fields of feedstock, techno-economic evaluation, markets, sustainability, dissemination, B2B communication and policy.

Pfeifer & Langen operates five sugar factories in Germany. Sugar beets grown by farmers are processed to white sugar and the by-products sugar beet pulp and molasses. These products and intermediate products such as thick juice can be used as carbohydrate sources for biotechnological processes.

Pfeifer & Langen supplies sugar and sugar specialities for the food industry and the consumers. The production process of Pfeifer & Langen starts when the sugar beet seed is sold to the farmers and ends when the sugar is placed on the shelves of groceries. We are looking for opportunities to use our expertise in the process chain beginning with agriculture and ending in the food retail trade for new processes and products connected with biotechnology.

Newly Pfeifer & Langen enters the field of natural functional carbohydrates.

Phytowelt GreenTechnologies GmbH is a young, innovative company offering contract research and production in plant and industrial biotechnology worldwide. Our tissue culture and genetic engineering know-how assists our clients for the optimization of plants as well as utilization of secondary metabolites and enzymes for industrial use.

Phytowelt routinely applies key technologies such as in vitro cultivation of plants, cell fusion, transformation technologies as well as plant analysis and molecular marker assisted breeding. Our approach to link plant and industrial biotechnology is maximizing the synergy from our platform technologies phytodiversity and phytomining to support the aroma and pharmaceutical industry and other users of secondary metabolites and enzymes of plants. Phytowelt GreenTechnologies was created in January 2006 as a merger of Phytowelt GmbH and GreenTec GmbH (created in 1997), a spin-off company from the Max-Planck-Institute for Plant Breeding Research, Cologne.

Senbis Polymer Innovations is a privately-owned company that supports its customers with applied (bio)polymer research. The young organization is building upon 25 years of experience in polymer research, as it used to be the former R&D department of AKZO and Diolen. Besides contract research, analysis and production for SMEs to multinationals, Senbis develops and produces its own products typically made from biopolymers. Examples are compostable yarns (PLA) for the horticulture industry, biodegreadable fishing nets or trimmerlines. The company also has a strong focus on (mono)filaments for 3D printing. Please contact us if we can support you in developing your biodegreadable application.

SenseUp develops microbial strains for the large-scale production of amino acids, recombinant proteins and for non-GM applications in feed- and food products. Using its patented evolution-based screening technology enables SenseUp to develop strains under process conditions. This ensures up-scale compatibility and short development time, accompanied by systematic generation of novel IP. As a spinoff from Forschungszentrum Jülich SenseUp combines decades of experience in microbial strain-development with novel disruptive technologies.

Senzyme GmbH is innovatively operating in biotechnology and develops and produces technical enzymes and other additives for applications in bioenergy, biorefinement, as well as in the food and feed industries. The company has a long and substantial experience in the cultivation of fungi using solid-state fermentation as the preferred method. Senzyme GmbH maintains a quality management system and guarantees for the effectivness and quality of all its processes and products. The company allways wellcomes cooperations with scientific institutions and other companies.

As an ‘all-in-one’ protein engineering service provider, SeSaM-Biotech improves industrial enzymes for various industry sectors like the chemical, dish&fabric, feed and food sector. Our expertise covers a range of enzymes including amylases, lipases, esterases, cellulases, glucose oxidases, laccases, monooxygenases, phytases, proteases, pectinases, polymerases and isomerases which we already have improved towards e.g. higher activity, thermal resistance or many other characteristics. With our cutting-edge technologies for mutagenesis (e.g. SeSaM-Technology, OmniChange), computational modelling of enzymes, and individually adapted screening assays we follow our vision:

To provide our clients with ‘Quality Enzyme Solutions’ to make their products eco-friendler, more cost effective and more valuable.

Stolmár & Partner is a full service IP law fi rm with offi ces in Munich, Düsseldorf and Geneva. A primary focus of S & P’s practice is life sciences, Biotech, Pharma, green chemistry, sustainable chemistry, where we provide assistance to our clients in creating, prosecuting and enforcing our clients’s valuable IP but we also give advice in complex licensing topics, IP Due Diligence, Freedom-to-Operate scenarios, document protection and arbitration in DIS based proceedings, ICCC and WIPO proceedings. Our technically and legally highly qualifi ed attorneys understand the technology of our clients and that IP does matter and provide with their sound experience also services before various national patent offi ces, including the European, the German, Swiss, Austrian, Italian and French Patent- and Trademark Offi ces as a truly European one-stop-shop for IP. S& P clients range from Research institutions, start-up companies to multinational DAX, KOSPI, JPX and Fortune 500 companies.

Swissaustral Biotech SA offers access to unparalleled natural biodiversity through its proprietary collection of unique extremophilic microorganisms isolated from a wide range of extreme environments. Our distinctive proprietary platform for discovery, isolation and characterization of enzymes and/or small molecule secondary metabolites from extremophiles, places us at the front of the field of natural product discovery. Swissaustral core competences in activity assay development ensures the “hunt down” of the right enzymes for your company with the desired characteristics in terms of stability, activity, pH, and temperature range.

Syngip is a next generation carbon capture biotechnology company. Syngip engineers carboxydotrophic bacteria to produce biochemicals and biofuels from syngas and carbon waste gases (gases containing CO and/or CO2, H2). Currently, the main focus lies on the development of microbial biocatalysts for the production of light olefins.

Especially the major target isobutene is an important building block for plastics, rubbers and fuels. Global consumption of isobutene is over 15 million tons per year. Production of isobutene from syngas or industrial waste gases is a very innovative approach to reduce climate destroying greenhouse gases, enable a circular economy and off er an alternative to petrochemical production routes. Syngip has been acquired in 2017 by Global Bioenergies, who already developed an isobutene production process from sugar in E. coli.

CeBiTec is one of the largest faculty-spanning central academic institutions at Bielefeld University. Its purpose is to bundle the biotechnological activities and research projects at the university, to foster cross-linking of research approaches and technologies from different research fields and to develop innovative projects within its two main research areas ‘Large Scale Genomics and Big Data Bioinformatics’ and ‘Metabolic Engineering of Unicellular Systems and Bioproduction’.

The availability of comprehensive technological infrastructure as being provided by CeBiTec’s Technology Platforms is crucial for a successful scientific work. The Graduate Center creates an inspiring interdisciplinary environment for high-level academic training of graduates. Furthermore, the CeBiTec considers itself as a central communication platform and a ‘think tank’ of the university with respect to initiatives and activities with a dedicated biotechnological perspective.

The Federal Institute for Materials Research and Testing (BAM) is a research facility under the authority of the Ministry of Economics and Technology. Its competences are to improve safety and reliability in chemical and materials technologies through research, testing, analysis, and information. The division Biodeterioration and Reference Organisms performs research and development in the field of i) materials protection against biological deterioration and ii) biotechnology with bacteria. We are especially interested in biotechnology and molecular biology of bacteria from extreme environments. Our expertise in molecular biology with extremophiles comprises a wide range of technologies to manipulate metabolic pathways with the goal to improve productivity of strains currently used in industry.

Eindhoven University of Technology (TU/e) is a research university, founded in 1956, specializing in engineering science & technology. The Department of Chemical Engineering and Chemistry aspires to be an academic institution for education and research in chemical science and engineering of the highest international standard. The aim is to generate and to develop technology and scientific knowledge relevant for the long-term needs of society. Scientific curiosity and the use of newly generated knowledge are the main driving forces behind the continuing enhancement of our expertise in (electro-)chemical reactor engineering, multiscale & multiphase modelling, process intensification, membrane processes and heterogeneous catalysis.

Russian Academy of Sciences was organized through merging the A.N. Bach Institute of Biochemistry RAS (INBI RAS), the S.N. Winogradsky Institute of Microbiology RAS and the Centre «Bioengineering» RAS.

The Research Centre of Biotechnology RAS carries out basic and applied research in the fields of biochemistry and biotechnology, microbiology, genomics, bioengineering and genetic engineering, biocatalysis, system and structural biology, biogeotechnologies, bioremediation, agrobiotechnologies, food quality and safety.

The Centre is the key member of the Russian Technology Platform «Bioindustry and Bioresources– BioTech2030». The Russian National Contact Point on Biotechnology, three core facilities, an accredited testing laboratory, and an experimental greenhouse are functioning at the Centre.

Within “Sustainable Chemistry”, VITO focuses on process intensification and replacing fossil with sustainable resources. Key is the integration of conversion with separation processes to improve overall efficiency and sustainability: in situ product recovery within fermentation processes, enzyme and catalyst immobilization, and novel separation approaches (membranes are often integrated in these processes) are some of our developments in this field. Using alternative resources (like CO2, biomass) requests different approaches to deliver high added value products: mild disclosure, (scCO2) extraction, fractionation and fermentation processes, (bio)electrochemical reactions with CO2. VITO is one of the partners involved in the inventories and strategic research agenda for “Sustainable Chemistry” especially in the European context (BIG-C, SPIRE, BBI), but also on a global level (India). VITO is also founding partner of Biorizon, a shared research centre for bio-aromatics.

IBG-1: Biotechnology (formerly Institute of Biotechnology) is one of Germany’s leading institutes in the field of microbial biotechnology. IBG-1 develops multipurpose microbial production platforms such as C. glutamicum for the production of industrially or pharmaceutically relevant products from renewable carbon sources (e.g. amino acids, organic acids, proteins). Methods of synthetic biology are used for establishing novel concepts in strain development and implementation of heterologous or artificial metabolic pathways. In parallel, biocatalysis with isolated enzymes or whole cells is developed using a rigorous systems biotechnology approach. IBG-1 runs an extensive “omics” platform including DNA microarrays, proteomics, metabolomics and fluxomics for strain characterization. Lab investigations are tightly integrated with mathematical modelling for experimental design, parameter estimation and process optimization. Experimental facilities range from parallelized mini bioreactor systems up to pilot plant scale and include tools for single-cell analysis by flow cytometry and microfluidics.

The Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB develops and optimizes processes and products in the fields of health, chemistry and process industry, as well as environment and energy. In the area of industrial biotechnology we focus on establishing, optimizing and scaling up processes that take place with the help of enzymes or microorganisms. For example, hydrolases and oxidoreductases as well as a wide variety of bacteria, fungi and yeasts are used for this purpose. In some cases, the desired conversion also becomes possible through combination with chemical transformation processes. In the development of the conversion processes under laboratory conditions and the optimization of the biocatalysts themselves, the focus is already on scaling up the processes and processing the products. At the Fraunhofer Center for Chemical-Biotechnological Processes CBP, the Leuna branch of the institute, infrastructure and pilot plants are available to scale up processes to production-relevant dimensions.

The Fraunhofer Institute for Molecular Biology and Applied Ecology IME conducts research in the field of applied life sciences from a molecular level to entire ecosystems. By strategic orientation along the value chain the Fraunhofer IME follows the mission to take innovative products closer towards the market, to develop enabling technologies and provide scientific services to partners from academic institutions and industry. In the area of industrial biotechnology, the Fraunhofer IME offers research in the field of directed evolution, classical strain improvement, metabolic pathway engineering, and fermentation. Besides scientific expertise, we possess state-of-the-art facilities for highthroughput screening, enzyme production & purification, fermentation process development and protein crystallization and modelling.

Fraunhofer UMSICHT is a pioneer for sustainable energy and raw materials management. The institute provides scientific results and transfers them to business, society, and politics. The dedicated team researches and develops sustainable products, processes and services.

We offer process engineering research and development services as well as products and processes incl. industrial property rights. These help to meet the increasing demands for affordable sustainability and innovation in chemistry, petro-chemistry and refinery. Our know-how encompasses the areas of fine and specialty chemicals (organic acids, peptides, sugars, surfactants), polymers (monomer syntheses, polymerization, polycondensation) as well as chemical mass products (alcohols, naphtha) and biofuels (diesel, kerosene). Biomass, synthesis gas and selected residues constitute the portfolio of raw materials from which we suggest process-specific solutions. Know-how regarding the upstream and downstream processing as well as product formulation round out our expertise.

The Fraunhofer Institut für Holzforschung, Wilhelm-Klauditz-Institut (WKI) works as closely and as application-oriented with the companies of the wood and furniture industries and the supplier industry as it does with the construction industry, the chemical industry and the automotive industry. Virtually all procedures and materials, which result from the research activities of the Institute, are used industrially. WKI has extensive competence in the areas of intermediates preparation from biosourced raw materials and polymer synthesis. The focus was laid on the modification of vegetable oils, saccharides, utilising building blocks generated by industrial biotechnology, and the utilisation of lignin for various applications for generating coatings, adhesives, sealants and elastomers. Outstanding developments and services of the Fraunhofer WKI were and are: - The development of innovative materials from chips and fibers - Natural-fiber composite plastics and further innovative hybrid materials - Environmentally-friendly and durable painting systems for furniture construction and exterior wood application - Building products, wood constructions and holistic concepts for the production of light and environmentally-compatible buildings - Process solutions for the recycling of production and post-consumer waste with the aim of achieving the highest possible level of reutilization - The testing and reduction of formaldehyde emissions from wood-based materials and furniture - The analysis of emissions from building materials and the reduction of VOC (Volatile Organic Compounds) and odorous substances - The testing and improvement of the properties of wood products through non-destructive methods such as thermography, ultrasound or magnetic resonance WKI stands for R&D along the value chain, starting with monomers to end-use applications.

The Institute of Molecular Enzyme Technology (IMET) of Heinrich-Heine-University Düsseldorf is located on campus of the Forschungszentrum Jülich where it is part of the Institute of Bio- and Geosciences IBG-1: Biotechnology which holds a leading position nationally and internationally in the field of basic research and biotechnological applications of microorganisms. IMET is directed by Prof. Dr. Karl-Erich Jaeger and currently employs about 50 people. Four different groups cover the scientific topics “Molecular Biophotonics” (Dr. Ulrich Krauss), “Bacterial Photobiotechnology” (Dr. Thomas Drepper), “Bacterial Enzymes” (Dr. Filip Kovacic), and “Bacterial protein production” (Dr. Andreas Knapp). IMET provides excellent facilities and comprehensive technical support including state-of-the-art instrumentation to carry out molecular biological, biochemical, and high-throughput screening methods.

Founded in 2009 Hamm-Lippstadt University of Applied Sciences has developed rapidly, currently counting 5.800 students in 14 Bachelor and 6 Master degree programs.The focus is on the students, professional and individual development is supported by practice-oriented teaching which is oriented towards the needs of the changing society and the dynamic working environment. Mentoring between scientific and practical experts, research marketing and reporting, founding, inventions and industrial property rights, promotion of cooperations between science, companies and institutions are the main tasks. With cooperative doctoral studies, the HSHL offers the opportunity for a further scientific qualification in research projects for qualified graduates of Master degree programs.

More and more companies and research projects analyze and optimize technical systems via Computational Fluid Dynamics (CFD). The IMH applies CFD to very complicated geometries with focus on two-phase flows and program. Furthermore the IMH programs and parallelizes additional software for commercial software programs.

Why not use the smallest factories to make the biggest possible amounts of high-value chemicals and pharmaceuticals- biosustainably? The Novo Nordisk Foundation Center for Biosustainability are doing exactly this by developing new technologies for engineering microbes, turning them into cell factories, which are designed for efficient production of a specific compound in a commercially competitive way. The Center is part of a cluster of research centers that aim at attracting the world´s best researchers, and thereby creating the basis for an internationally oriented and innovative research environment of the highest quality to benefit society.

Philipps-Universität in Marburg is the oldest university in the world that was founded as a Protestant institution. It has been a place of research and teaching for nearly five centuries. It`s broad range of arts and humanities, and its experimentally challenging scientific work, constitute an ideal platform for interdisciplinary cooperation.

The Philipps-Universität Marburg and the Max Planck Institute for Terrestrial Microbiology have established a center for Synthetic Microbiology, SYNMIKRO. Supported by the state of Hessen within its excellence program LOEWE. In SYNMIKRO research groups in the areas of microbiology, genetics, medicine, cell biology, chemistry, physics, mathematics, informatics, and bioethics are working together in an interdisciplinary approach focusing on basic research in synthetic biology on all levels of microbial function, ranging from the development of regulatory circuits, genetic codes and metabolic pathways to the synthesis of new minimal cells and microbial communities.

The Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT), Chinese Academy of Sciences is one of China’s primary national research institutions for renewable energy and green materials, focusing mainly on research and development of the resources, technologies, products and processes for bio-based energy and materials. QIBEBT currently has a staff of 800, 470 of whom are full-time employees and 330 are graduate students. The institute offers PhD, Master and Postdoctoral programs in biology, chemical engineering and technology, and material science and engineering. The institute attaches high importance to promoting international cooperation and has more than 170 global partners including Boeing, Shell, P&G and Total.

We are experts in biocatalyst engineering with a focus on directed protein evolution. We are developing novel random mutagenesis methods (SeSaM: Sequence Saturation Method), high throughput screening systems and computational programs to manage the complexity of protein sequence space. Based on our core competencies in directed protein evolution we founded a company (SeSaM-Biotech) and collaborate with leading companies in the field of industrial biotechnology.

With our expertise we aim to understand structure-function relationships of biocatalysts and functional biomaterials in order to solve significant problems in industrial biocatalysis.

Scion is a New Zealand Crown Research Institute that specialises in research, science and technology development for the forestry and wood-derived materials: tree improvement, wood-related bioenergy, industrial biotechnology and high-value manufacturing.

Scion is developing biorefinery processes to create new green chemicals and biopolymers from renewable resources, with a focus on lignocellulosic biomass: soft wood.

We develop microbial and enzyme-based processes that can be used by industrial partners for the production of valued compounds, enzymes and other biological products.

Scion is New Zealand's centre of expertise in bioplastic research and development: production and manufacturing of biopolymers as plastics, adhesives, coatings, foams, pulp/packaging, and fibre-composites.

The TH Köln - University of Technology, Arts, Sciences offers students and scientists from Germany and abroad an inspirational study and research environment in the social, cultural, engineering, and natural sciences. Currently there are more than 24,000 students from about 120 countries enrolled in over 90 bachelor's and master's programs of 11 interdisciplinary faculties. Climate change and scarce resources are some of the major challenges mankind will be facing in the coming decades. The faculty of Applied Natural Sciences at Campus Leverkusen engages itself in chemical and biotechnological research projects to address these `great challenges' and actively contributes to the advancement of science and economy.

The Department of Biochemical and Chemical Engineering (BCI) at TU Dortmund is the largest and one of the most successful engineering departments in Germany. It is active in all areas of biochemical and chemical engineering. The strength of the department is its multidisciplinarity, linking various research areas, such as thermodynamics, fluidics, biomaterials, chemical biotechnology and process engineering, thus covering all stages of (bio)process and (bio)catalyst development. The BCI is the initiator of the SusChemEng research network, bringing together academia and large and medium sized companies for the design and optimization of safe, environmentally friendly and sustainable processes and products for the chemical, pharmaceutical, and related industries.

To explore the potential of nature to improve the quality of life

Wageningen University and Research is a joint venture between the Wageningen University, which focuses on education and fundamental research, and Wageningen Research which conducts applied research directly for industry. In CLIB2021, the WUR is represented by five academic chair group - Bioprocess Engineering, Microbiology, Systems and Synthetic Biology, Environmental Technology and Biobased Commodity Chemistry – and by the applied research centre Food & Biobased Research (WFBR).

The groups study microbial processes intra-cellular, cellular, inter-cellular, reactor, and environmental scale with a strong link to the chemical industry. The generated knowledge at the University is translated into application, by WFBR, for production and biorefinery of pharmaceuticals, healthy food ingredients, bulk chemicals, and biofuels.

NRW.BANK is the state development bank of North Rhine-Westphalia. It essentially orients its equity products on the business life cycle. The program “NRW.SeedCap Digitale Wirtschaft” doubles initial investments of business angels in digital start-ups under the same conditions. The “NRW.BANK.Seed Fonds Initiative” and the “NRW.BANK.Venture Fonds” invigorate early-phase funding in NRW. Within the “win NRW.BANK Business Angels Initiative” private investors (business angels) support young entrepreneurs with capital and know-how. The “NRW.BANK.Venture Center” is a specialist advisory unit for business founders from universities and research institutions as well as innovative start-ups.

Sofinnova Partners is a leading European venture capital firm specialized in Life Sciences. Based in Paris, France, the firm brings together 12 highly experienced investment professionals from all over Europe, the US and China. The firm focuses on paradigm shifting technologies alongside visionary entrepreneurs.

Sofinnova Partners seeks to invest as a founding and lead investor in start-ups and corporate spin-offs, and for more than 40 years has backed nearly 500 companies creating market leaders around the globe. Today, Sofinnova Partners has over 1.3 billion of funds under Management.

Arnold & Porter Kaye Scholer is an international law firm with over 1,000 lawyers in 13 offices around the world. The Frankfurt Biotech/Pharma team has substantial experience relating to partnership alliances, licensing, technology transactions, distribution agreements, strategic partnerships and investments, protection of intellectual property, financing matters, corporate and tax optimized structuring. In our London office, a team of highly reputed attorneys is dedicated to regulatory issues in the chemicals, healthcare and other industries. The firm’s clients range from individuals and small/medium sized companies to large international corporations.

About 25 highly experienced attorneys in Frankfurt advise on law areas including Corporate, M&A, Finance, Antitrust, Pharma & Biotech, IP/Patent Litigation, Labor/Restructuring & Business Reorganization, Compliance, Tax, Litigation/Dispute Resolution, Restructuring & Insolvency.

BCNP Consultants GmbH is specialized in the industries biotech, chemistry, nanotech and pharma (BCNP). The three divisions of BCNP Consultants are: BCNP strategy On basis of our business analyses (market and competitor analysis, technology comparisons) you are able to design and sharpen your business model, to write the business case and to identify new M&A targets. BCNP connect On the basis of our vivid business networks in the life sciences industry we bring you together with relevant people in order to support you in filling your customer pipeline. European Chemistry Partnering Since 2017 innovators – from chemistry to bio-economy, from engineering to digitization - have been meeting twice a year: In February at the European Chemistry Partnering and in September at the ECP Summer Summit.

Your reliable partner for scouting, bioprojects and consultation.

Featuring:

“Window to China” - provides you with competent and up-to-date information on Chinese bio R&D, based on press releases, reports and professional network information in Chinese language. Overcome the language barrier and stay informed about the growing biocommunity of China!

Other features:

„Window to Japan“ - newsletter, website and database

„Profiler“ - whom are you talking to in China and Japan?

„Customer search“ - an evidence-based approach to Marketing

Located in Sarnia, Ontario, Canada, Bioindustrial Innovation Canada (BIC) focus is to help Ontario and Canada become a globally recognized leader in taking sustainable feedstock, such as agricultural and forestry by-products and wastes, and turning these renewable resources into energy and value-added chemicals for use in applications ranging from construction to automotive parts. We provide critical, strategic investment, advice and services to business developers of clean, green and sustainable technologies. Our expertise in commercialization builds a stronger Canada. BIC has played a key role in attracting anchor companies to the Sarnia-Lambton region, which will form key components in the cluster’s value chain. Securing the location of these anchor companies in Sarnia is expected to attract significant follow-on investment to the region. BIC is expanding its current business support model and accelerator facility to launch the Centre for Commercialization of Sustainable Chemistry Innovation (COMM SCI). COMM SCI will be a hub for commercialization of sustainable chemistry and bio-based innovation, providing business and technical support to participating SMEs (Small and Medium Enterprises). COMM SCI services will offer participating companies expert training, mentorship, and access to risk capital for technology demonstration and scale-up.

BioIndustry e. V. is a registered association whose main purpose is to activate, concentrate and develop biotechnological competences in the Ruhr region. The key aspects of BioIndustry‘s activity are industrial biotechnology and bioprocessing technologies, microstructure technology, X-omics and bioinformatics. As a networking service cluster of 50 companies, research and training institutes, technology centres, biotechnological service providers and public business development organizations, the associations objective is to generate product- and process-innovations. This objective will be met by supporting the active transfer from ideas to market.

BioRiver - Joining forces for Life Sciences & Biotechnology

Founded in 2004, BioRiver – Life Science im Rheinland e.V. is fully committed to representing the Life Sciences sector in the bioregion Rhineland as an independent industry organization. The essential aims of BioRiver are to build a strong network within the biotech sector, to improve the political and economic conditions as well as to market the bioregion Rhineland and its members. Thanks to the strong profiles of the partners in the network, it has been possible to initiate various collaboration projects and gain direct access to experts in both business and academia.

CREAGO Solutions UG offers strategy, innovation managament & technology management consultancy and support for small and medium sized companies (SME´s). We act as classical consultants as well as interims managers or service providers for our clients. CREAGO Solutions has a strong focus an SME´s within the chemical industry, biotechnology and plastics processing industry. Our service is based on a long lasting practical experience within a multinational specialty chemicals company and we are part of a strong network of well-known and experienced partners and industry experts.

The chemical department of the intellectual property law firm Eder Schieschke & Partner mbB has specialized in representing clients in the field of organic chemistry, biochemistry and biotechnology before the European Patent Office, the German Patent and Trademark Office, the German Patent Court and the European Intellectual Property Organization in all areas of intellectual property law. Amongst obtaining patent rights, utility model rights and trademark rights Eder Schieschke & Partner mbB’s expertise is also directed to license agreements, preparation of invalidity, infringement and freedom-to-operate studies, as well as German employee law. As a member of CLIB, Eder Schieschke & Partner mbB is supporting the Cluster with the realization of IP coaching seminars for start-ups and SMEs.

The Industrial Biotechnology Innovation Centre’s (IBioIC) role, as a specialist in the Industrial Biotechnology (IB) sector, is to stimulate the growth of the IB sector in Scotland to £900 million by 2025. IBioIC connects industry, academia and government and facilitates collaborations, provides scale-up capabilities, creates networks and develops skills. IBioIC supports transition into IB by helping companies to understand the benefits and opportunities, overcome any barriers and to make sure our members are in touch with the right people to guide them through the technology and its consequent translation and implementation in their business.

The international protection of Intellectual Property (IP) is of great importance for successful collaboration and commercialization. The successful protection of biotechnological inventions e.g. representing one part of a complete value chain requests a sound experimental set-up from the initial idea to patent filing. IP Services assists throughout the process of translating ideas into valuable Intellectual Property Rights. Based on a 17 year experience in a Biotech company working as project manager and IP manager in the field of recombinant expression in yeast I started my own business in 2005. The objective is to represent the interface between a company and a law firm and providing any IP service needed by small or mid-sized Biotech companies on a cost efficient basis and independent of the company’s location. The service comprises assessing the value of a company’s technologies, collaboration with R&D t, IP searches, definition of patent filing strategy, analysis and maintenance of IP portfolio, patent application processing, cooperation with law firms, preparation for due diligence (M&A processes), IP administration, Cost control and IP training.

KADIB offers comprehensive expertise in Industrial Bioeconomy. We provide consultancy in positioning profitable chemical and energy value chains in your Political, Economical, Societal, Technological, Legislative and Ecological (PESTLE) environment. KADIB provides advice and moderates decision-making in - Analysing the Bioeconomy Potential - Designing strategic Bioeconomy Concepts - Implementing Bioeconomy Strategies - focusing on Markets, Technologies and Business Opportunities - for Industries, Research Institutes, Governmental Agencies KADIB works through its unique network of senior experts. KADIB is a member of CLIB-Cluster (Cluster Industrial Bioeconomy) and BioBall (Bioeconomy in Metropolitan Regions).

Bioeconomy Corporation is the lead development agency for the bio-based industry in Malaysia, under the purview of Ministry of Science, Technology, and Innovation (MOSTI). Bioeconomy Corporation is:

- Owned by the Minister of Finance Incorporated & Federal Lands Commissioner

- Governed by the Biotechnology Implementation Council

- Advised by the Bioeconomy International Advisory Panel, chaired by the Honorable Prime Minister of Malaysia.

Bioeconomy Corporation is responsible for executing the objectives of the National Biotechnology Policy (NBP) and acts to identify value propositions in both R&D and commerce and to support these ventures via financial assistance and developmental Services.

PROvendis acts as a professional service provider in the entire field of IP management for more than 30 universities and extra-university research institutions as well as for companies and start-ups.

We provide an exclusive access to licensable inventions of approx. 20,000 scientists from the areas of medicine, natural sciences and engineering. Our Life Sciences Team consists of experienced innovation managers with professional expertise in the fields of biology, chemistry, medicine and pharma. They identify suitable partners, negotiate license agreements and promote long-term research collaborations.

RatnerPrestia, founded in 1981, is a U.S. based intellectual property law firm with significant clients headquartered around the globe. RP has four offices, three in the US and one in Munich, that seamlessly provide a transatlantic team of experts. RP has specialists in the field of biotechnology in USA as well as in Germany and additionally has a great network of biotech specialists in Asia. The firm has insight in the companies needs in terms of IP management and handles clients of all sizes and experience, from consulting with inventors through application drafting and patent procurement, to obtain protection for their ideas and enforce their rights.

Saint-Hyacinthe Technopole manages economic development on the city of Saint-Hyacinthe’s territory. Its mission is to attract new industrial and commercial businesses, as well as promote and develop tourism. One of the Technopole’s main tasks is to attract potential investors to the Maskoutan region. It works closely with investors to help get their projects set up in our area and ensure their success. It also manages and develops the technology park, the City of Agri-Food, Veterinary and Agri-Environmental Biotechnology. The Technopole is in charge of managing and selling lots in the industrial parks. The Technopole also helps established businesses in the city centre with their development projects, namely by securing financing packages and guiding them.

Schnee Research sees itself as a mediator between financial markets (e.g. investors) and small to mid-sized companies in different areas (e.g. biotech, chemical industry). Having worked for some years as analyst in the financial industry (independent research house, and rating agency), I now keep strong ties to the chemical industry from by background as a trained chemist (Dipl.-Chem.) and to biotech from my thesis work. My business activities in the area of white biotechnology are focused on evaluation and scouting. I focus on the analysis and evaluation of privately owned as well as listed biotech companies or their development projects. I was contracted as independent specialist by an investment bank to consult and assist a white biotechnology company in obtaining funding. Schnee Research offers two different services directly or via its cooperation partners faireseach (pure-play financial research) and Breslin. As a consequence, Schnee Research can span an investment bank’s value chain with its entire network. The services of Schnee Research are closer to the money market than to production.

SolarBioproducts Ruhr was founded by the Business development agency Herne in cooperation with th Photobiotechnology Group (Ruhr-UNiversity Bochum). SolarBioproducts Ruhr aims to intensify Research Projects, develop innovative ideas and bring together differnt fields of study. We offer outstanding experience in the field of green biotechnology, including in-depth knowladge of biocatalysis from photosynthetic microorganisms. Our Team is interested in collaborations across a broad range of fields. our experience in gene Expression and genetic Manipulation is applicable in the field of renewable energy, but also for bioeconomical alternatives for industrial applications like the use of microorganisms as Chassis for the production of chemical compounds or high-value products.

The “Verband der Chemischen Industrie e. V. NRW” (the Chemical Industry Association in North Rhine-Westphalia) represents the politico-economic interests of more than 500 NRW chemical companies and NRW subsidiaries of foreign enterprises in contacts with politicians, public authorities, other industries, the world of science, and the media. VCI NRW represents about 30 % of the entire German chemical industry, an industry that realised sales of € 49.7 billion in 2015 and employed some 100,000 staff. A main focus of the last years was the interlinking of industry and science especially in the area of biotechnology. The association’s policies are shaped by a presidential council which works in an honorary capacity and the VCI NRW executive management.

Yncoris places particular emphasis on the engineering of individual plants - from process development and conceptual design to basic and detailed engineering, regardless of whether we just carry out sub-services or take over the general planning for every stage. Yncoris does not supply one-size-fits-all solutions. Instead, we adopt a flexible approach and gear ourselves towards the specific requirements of the current project stage - step-by-step. Thanks to a broad range of diverse engineering fields and an extensive selection of methods, we can guarantee the highest degree of flexibility with regard to content. The Chemiepark Knapsack near Cologne in Germany also offers companies a scale-up platform and access to know-how for bio-based production and integration into existing value chains. The innovative capacity of the Chemiepark Knapsack, solid infrastructure, plug&play services, as well as less bureaucracy and red tape all offer huge benefits for your company to commercialize your product.